compliance issues reimbursing glp-1 weight loss treatments multiple states Prescription Drug Spending Surges in 2024, Led by GLP-1s MEDVi GLP-1 Weight Loss: Insurance-Free
Description
These medications work by mimicking the action of GLP-1, thereby helping to regulate blood sugar levels and reduce appetite
This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio.
In a trial, people lost 75% fat and 25% muscle.
A non-injectable, non-stimulant alternative to GLP-1 drugs
Methods Individual-level analyses incorporating real-world effectiveness and cost data were conducted for a cohort of 1022 propensity-score-matched pairs of GLP-1RA and insulin users from Taiwans National Health Insurance Research Database, 20072016
